Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Asset Writedowns and Impairment (2019 - 2025)

InfuSystem Holdings (INFU) has disclosed Asset Writedowns and Impairment for 10 consecutive years, with $417000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment fell 61.5% year-over-year to $417000.0, compared with a TTM value of $519000.0 through Dec 2025, down 44.9%, and an annual FY2025 reading of $519000.0, down 44.9% over the prior year.
  • Asset Writedowns and Impairment was $417000.0 for Q4 2025 at InfuSystem Holdings, up from -$278000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.2 million in Q3 2023 and bottomed at -$1.5 million in Q4 2023.
  • Average Asset Writedowns and Impairment over 5 years is $68200.0, with a median of $88000.0 recorded in 2024.
  • The sharpest move saw Asset Writedowns and Impairment plummeted 6818.18% in 2021, then soared 1467.78% in 2023.
  • Year by year, Asset Writedowns and Impairment stood at $176000.0 in 2021, then decreased by 2.84% to $171000.0 in 2022, then plummeted by 1000.0% to -$1.5 million in 2023, then soared by 170.37% to $1.1 million in 2024, then crashed by 61.5% to $417000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for INFU at $417000.0 in Q4 2025, -$278000.0 in Q3 2025, and $123000.0 in Q2 2025.